Clincosm LogoSign in Get a demo

Micro-RNA Expression Profiles in High Risk Prostate Cancer

Sponsor
Wuerzburg University Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT01220427
Collaborator
Universitaire Ziekenhuizen Leuven (Other)
300
Enrollment
1
Location

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether specific Micro-RNA expression profiles are related to Prostate cancer outcome.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Time Perspective:
    Retrospective
    Official Title:
    Micro-RNA Expression Profiles in High Risk Prostate Cancer
    Study Start Date :
    Jun 1, 2007

    Arms and Interventions

    Arm Intervention/Treatment
    Clinical high-risk prostate cancer, radical prostatectomy

    Outcome Measures

    Primary Outcome Measures

    1. Recurrence free survival [Yearly update until clinical progression]

      The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.

    Secondary Outcome Measures

    1. Cancer specific survival [Yearly update until death]

      The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly until death.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    35 Years to 80 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Patients with clinically localised high risk prostate cancer (cT>2, bx GS >7, PSA >20 ng/ml) scheduled for radical prostatectomy.

    Exclusion Criteria:

    Non high risk prostate cancer

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Urology and Pediatric Urology University Hospital Würzburg Würzburg Germany 97080

    Sponsors and Collaborators

    • Wuerzburg University Hospital
    • Universitaire Ziekenhuizen Leuven

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01220427
    Other Study ID Numbers:
    • mi-RNA HR-Pca
    First Posted:
    Oct 13, 2010
    Last Update Posted:
    Mar 3, 2016
    Last Verified:
    Aug 1, 2010
    Keywords provided by , ,
    high-risk prostate cancer
    radical prostatectomy
    micro-RNA
    Additional relevant MeSH terms:
    Prostatic Neoplasms

    Study Results

    No Results Posted as of Mar 3, 2016